Time to act on drug safety

JAMA. 1998 May 20;279(19):1571-3. doi: 10.1001/jama.279.19.1571.

Authors

T J Moore¹, B M Psaty, C D Furberg

Affiliation

¹ Center for Health Policy Research, the George Washington University Medical Center, Washington, DC 20006, USA. ihotjm.gwumc.edu.

PMID: 9605903
DOI: 10.1001/jama.279.19.1571

No abstract available

MeSH terms

Drug Industry
Legislation, Drug*
Product Surveillance, Postmarketing*
United States
United States Food and Drug Administration*